Despite an over 86 percent gain in the stock in 2023 YTD, domestic brokerage house Investec sees pharma firm Orchid Pharma (ORCD) rising another 23 percent in the next 12 months. The brokerage has initiated coverage on the stock with a ‘buy’ call and a target price of ₹800.
Radiance Renewables, backed by Eversource Capital, has hired Rothschild & Co. to sell its platform serving commercial and industrial customers in a deal valued at around $150m. The company currently has an operational portfolio of 500 MW and plans to increase capacity to 2 GW over three years.
FINTECH DIGITAL FORUM TO INTEGRATE OPPORTUNITIES FOR INDUSTRY LEADERS sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.